Global Recombinant Proteins Market Size, Status and Forecast 2020-2026

Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Abcam PLC was the largest company in the global Recombinant Proteins market, with a revenue market share of 13% in 2018.

Top 5 companies occupied 40% of the market.

By region, Europe was the biggest region, with a revenue market share over 33%, and North America ranked 2. Asia-Pacific ranked 3, and its market grew fastest.
Market Analysis and Insights: Global Recombinant Proteins Market
In 2019, the global Recombinant Proteins market size was US$ 612 million and it is expected to reach US$ 1062 million by the end of 2026, with a CAGR of 8.1% during 2021-2026.
Global Recombinant Proteins Scope and Market Size
Recombinant Proteins market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Proteins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Recombinant Proteins market is segmented into Hormones, Growth Factors, Cytokines, Plasma Protein Factor, Recombinant Metabolic Enzymes, Immune Checkpoint Regulators, Others, etc.
Segment by Application, the Recombinant Proteins market is segmented into Biopharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations, etc.
Regional and Country-level Analysis
The Recombinant Proteins market is analysed and market size information is provided by regions (countries).
The key regions covered in the Recombinant Proteins market report are North America, Europe, China, Japan, Middle East, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Recombinant Proteins Market Share Analysis
Recombinant Proteins market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Recombinant Proteins business, the date to enter into the Recombinant Proteins market, Recombinant Proteins product introduction, recent developments, etc.
The major vendors include Abcam PLC, R&D Systems, Miltenyi Biotec, Thermo Fisher Scientific, Sigma Aldrich Company, GE Healthcare, Lonza, Merck KGaA, ProSpec Tany TechnoGene, Eurogentec (Kaneka Corporation), PeproTech, BPS Bioscience, Reprocell, GenScript Biotech Corporation, Abnova Corporation, etc.

This report focuses on the global Recombinant Proteins status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Recombinant Proteins development in North America, Europe, China, Japan, Middle East, India and Central & South America.

The key players covered in this study

Abcam PLC
R&D Systems
Miltenyi Biotec
Thermo Fisher Scientific
Sigma Aldrich Company
GE Healthcare
Lonza
Merck KGaA
ProSpec Tany TechnoGene
Eurogentec (Kaneka Corporation)
PeproTech
BPS Bioscience
Reprocell
GenScript Biotech Corporation
Abnova Corporation

Market segment by Type, the product can be split into

Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Hormones and Cytokines were the two largest segments of Recombinant Protein in global market, with market shares of 26% and 22% respectively in 2018.

Market segment by Application, split into

Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Recombinant Protein was used in Biopharmaceutical Companies widest, with a proportion of 62% in 2018.

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Middle East
India
Central & South America

The study objectives of this report are:

To analyze global Recombinant Proteins status, future forecast, growth opportunity, key market and key players.
To present the Recombinant Proteins development in North America, Europe, China, Japan, Middle East, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Recombinant Proteins are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.